Medable Inc
PrivateLast Round
Series D
Oct 26, 2021
Est. Valuation
$2.1B
Total Funding Raised
$506.94M
Company Overview
Medable Inc is a healthcare technology company that provides a cloud-based platform designed to support decentralized clinical trials by streamlining study design, patient recruitment, and data collection.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Patient Engagement, Vertical SaaS, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medable Inc Comparables
Compare Medable Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| THREAD | 90% | |
| eMed | 86% | |
| Signant Health | 86% |
Medable Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Oct 26, 2021 | ||||
| Series C Extension | Apr 15, 2021 | ||||
| Series C | Nov 19, 2020 | ||||
| Series B | May 4, 2020 | ||||
| Series A Extension | Feb 24, 2017 | ||||
Series A | Dec 4, 2015 |
Key People
Founding team and executive leadership
Medable Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Launchpad Digital Health | Series A, Series A Extension, Accelerator |
| HealthX Ventures | Series A, Series A Extension |
| Streamlined Ventures | Series C, Series C Extension |
| GSR Ventures | Series C, Series C Extension, Series D, Series B |
| Obvious Ventures | Series C Extension |
| Blackstone Growth | Series D |
| Sapphire Ventures | Series D, Series C, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
Launched an AI Agent to streamline Trial Master File processes.
- Sep 17, 2025
Named a Leader in Everest Group's 2025 eCOA Products PEAK Matrix.
Recent news
Latest coverage and updates
- launchesSep 1, 2026
Medable launched Intelligent Consent on Sep 1st '26.
- integrates_withAug 26, 2026
Medable integrates with Oracle Corporation.
- partners_withAug 19, 2026
Medable partners with Tufts.
Medable Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Medable Inc's valuation, stock price, and market status.
Is Medable Inc a public or private company?
Medable Inc is a private company.
What is the current stock price of Medable Inc?
Medable Inc is a private company with no public stock price. Caplight tracks Medable Inc's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Medable Inc worth (valuation)?
Medable Inc's valuation is estimated at $2.1B based on funding round data.
Can I buy Medable Inc stock?
Medable Inc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Medable Inc's last funding round?
Medable Inc's most recent funding round was Series D on October 26, 2021.
Who are the main investors in Medable Inc?
Key investors in Medable Inc include Launchpad Digital Health, HealthX Ventures, GSR Ventures, Blackstone Growth, Sapphire Ventures.
Will Medable Inc IPO soon?
No public IPO plans have been announced for Medable Inc.
How can I track Medable Inc secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medable Inc's secondary market activity and sign up for updates.